Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial

DiscussionThe present study was approved and conducted as an initiative study of the Japanese Association for Acute Medicine. If non-inferiority is identified, the society will pursue an application for the national health insurance coverage of levetiracetam for SE via a public knowledge-based application.Trial registrationJapan Registry of Clinical TrialsjRCTs031190160. Registered on December 13, 2019
Source: Trials - Category: Research Source Type: clinical trials